AUTHORS

Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

Here's a Handful of Small Biotechs Where Insiders Are Buying

Quotient Limited, Iovance Biotherapeutics and AVEO Pharmaceuticals are among the names seeing insider purchases.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

3 Profitable Small Biotech Names to Consider

Exelixis Inc., ANI Pharmaceuticals and Supernus Pharmaceuticals should not need to raise more capital in the foreseeable future.

A Way to Exploit Algorithm-Induced Market Swings When Trading Biotech Issues

It can be disturbing to see various names lose value quickly on no news, but here is a method to take advantage of such moves.

Tuesday Felt Like a Knee Jerk Selloff

Will cooler heads prevail Thursday after investors have had an extra day to reassess the actual situation?

Stocks to Buy Into a Year-End Rally

The likelihood of a seasonal rally is rising -- here is how to play it.

Here's Why Homebuilders Are Getting a Lift

I still like some of the names in this sector to rally further off oversold levels.

2 Small Biotech Stocks That Insiders Are Buying

Both names looked poised to go higher as soon as sentiment around the small biotech sector improves.

The Market Is Cheaper Than in Years, and Beaten-Down Sectors May Be Bottoming

The S&P 500 began the year selling at 18.2x forward earnings. It is now at around 15x projected earnings.

3 Black Friday Bargains: Olin, Entercom and Energy Transfer

These stocks are deep in bargain territory.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight